Drawing for AZANTA

USPTO serial 79078743

AZANTA

Reviewed by CopyMark Law Group

Reg. 3853925Status 404
Filing date
Status date
Registration date
Sep 28, 2010
Examiner
MIDDLETON, BERNICE L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AZANTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological services and research and design in the fields of oncology, pain and drug abuse, and women's health; industrial analysis and research relating to the development of drugs for treatment in the fields of oncology, pain and drug abuse, and women's healthSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 28, 2020DETHDEATH OF INTERNATIONAL REGISTRATION
Feb 23, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jan 19, 2018INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 19, 2018INPCINVALIDATION PROCESSED
Jan 5, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 11, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED
May 5, 2017C71TCANCELLED SECTION 71
Sep 28, 2015REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 10, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 24, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 18, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB
Jan 18, 2011FIMPFINAL DISPOSITION PROCESSED
Dec 28, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 28, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 13, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 23, 2010NPUBNOTICE OF PUBLICATION
Jun 4, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 3, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 28, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2010ALIEASSIGNED TO LIE
May 14, 2010RFNTREFUSAL PROCESSED BY IB
May 12, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2010RFRRREFUSAL PROCESSED BY MPU
Mar 31, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 30, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2010DOCKASSIGNED TO EXAMINER
Mar 2, 2010MAFRAPPLICATION FILING RECEIPT MAILED
Feb 26, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2010REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance